CTLA4 and neoplasm: However, simultaneous inhibition of the B7-CTLA-4 pathway by an anti-CTLA-4 antibody may increase the number of activated CD8+ T cells in lymph nodes, followed by an increase in the number of activated CD8+ T cells infiltrating into tumoural tissues, thereby enhancing their antitumour effects.